Zenith Epigenetics Corp
44 Montgomery Street
About Zenith Epigenetics Corp
Zenith Epigenetics is a clinical stage biotechnology company with a broad and deep drug discovery platform in epigenetics, developing orally active, small molecules that are selective for inhibition of BET bromodomains. This platform integrates structural biology, modeling, medicinal chemistry with biochemical and cell-based assays to discover potent compounds which are then further evaluated for desirable pharmaceutical properties, including oral bioavailability, and in animal models of disease. Through ongoing discovery activities we are continuing to secure intellectual property around novel compounds and their analogs.
CEO: Donald J. McCaffrey
CBO: Sanjay Lakhotia
CFO: A. Brad Cann
Please click here for Zenith Epigenetics job opportunities.
Please click here for clinical trial information.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.